United Therapeutics Announces FDA Clearance of Pig Transplantation Clinical Trial
On Feb. 3, 2025, United Therapeutics, a public benefit corporation, announced that the U.S.Food and Drug Administration (FDA)…
FDA approves Ozempic® (semaglutide) as only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and CKD
On Jan. 28, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic® to…
The effect of nirmatrelvir-ritonavir on short- and long-term adverse outcomes from COVID-19 among patients with kidney disease
On Dec. 31, 2024, a study was published of patients with kidney disease who are at high risk…
United Therapeutics Announced World’s First Successful UKidney Transplant
On Dec. 17, 2024, United Therapeutics, a public benefit corporation, announced the world’s first transplant of a UKidney,…
Study showed Even Low Levels Of Arsenic In Drinking Water Raise Kidney Cancer Risk
On Dec. 2, 2024, researchers from the Texas A&M University School of Public Health reported a study that showed exposure…
FDA Investigation of E. coli outbreak from McDonald’s Onions Completed
On Nov. 13, 2024, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Radiology | Therapeutics | Women's Health
NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs
On Jul. 24, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Oncology | Therapeutics
Analysis identified 50 new genomic regions associated with kidney cancer risk
On Apr. 26, 2024, an international team of researchers led by the National Cancer Institute (NCI) released an…
First-ever combined heart pump & gene-edited pig kidney transplant gives new hope to patient with terminal illness
On Apr. 24, 2024, surgeons at NYU Langone Health announced they had performed the first combined mechanical heart…
Eledon Pharma announced use of tegoprubart in first-ever transplant of genetically modified kidney from a pig to a human
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
In a first, genetically edited pig kidney was transplanted into a human
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Non-Profit Research | Therapeutics | Vaccine
First Tissue Bank May Help Solve Mystery of Long COVID Misery
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
U.S. Centers for Disease Control and Prevention warned of E. Coli outbreak linked to raw milk cheese
On Feb. 16, 2024, the U.S. Centers for Disease Control and Prevention announced that ten people infected with…
W. Kimryn Rathmell, M.D., Ph.D., began work as 17th director of the National Cancer Institute
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
Pig kidney xenotransplantation performed optimally after 32 days in human body
On Aug. 16, 2023, surgeons at NYU Langone Health announed they had transplanted a genetically engineered pig kidney…
NIH released new atlas of human kidney cells to help unlock kidney disease research
On Jul. 19, 2023, the National Institute of Health announced that a nationwide research team had created the…
U.S. FDA approved Vekluryï¾® (Remdesivir) for COVID-19 treatment in patients with Severe renal impairment
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
NYU Langone Health’s Groundbreaking Transplant Offers Hope amid Organ Shortages
On Oct. 19, 2021, the first investigational transplant of a genetically engineered, nonhuman kidney to a human body…
OPKO Health completed enrollment in phase 2 trial evaluating RAYALDEE as treatment forsymptomatic COVID-19 outpatients
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEï¾® as a…
NIH launched study of third COVID-19 vaccine dose in kidney transplant recipients
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
FDA approved treatment for chronic kidney disease
On Apr. 30, 2021, the FDA approved AstraZeneca’s Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney…
FDA approved Aurinia Pharmaceuticals LUPKYNIS (voclosporin) for adults with active lupus nephritis
On Jan. 22, 2021, Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA)Â had approved LUPKYNISTM…
Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacity
On Dec. 15, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
Research confirmed obesity is a cause of kidney disease
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
Aurinia announced European trial to evaluate antiviral activity of Voclosporin in kidney transplant recipients with COVID-19
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
OPKO Health initiated clinical trial of RAYALDEE in COVID-19 patients
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEï¾® as a…
Kidney transplantation between people with HIV is safe, NIH study found
On Jul. 23, 2020, kidney transplantation from deceased donors with HIV to people living with both HIV and…
From lung scarring to heart damage, COVID-19 may leave lingering marks
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
FDA authorized OPKO Health clinical trial evaluating RAYALDEE in COVID-19 patients
On Jun. 1, 2020, OPKO Health announced the FDA had authorized OPKO to undertake a Phase 2 trial…